NATCO Pharma Limited (NSE:NATCOPHARM)
India
· Delayed Price · Currency is INR 797.95
+4.80 (0.61%)
Feb 21, 2025, 3:30 PM IST
NATCO Pharma Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Net Income | - | 13,883 | 7,153 | 1,700 | 4,409 | 4,608 | Upgrade
|
| Depreciation & Amortization | - | 1,822 | 1,592 | 1,394 | 1,145 | 973 | Upgrade
|
| Other Amortization | - | 46 | 46 | 32 | 24 | 25 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 17 | -178 | -427 | -320 | -163 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 23 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 7 | 52 | -12 | - | - | Upgrade
|
| Stock-Based Compensation | - | - | - | 22 | 126 | 144 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 278 | -131 | 470 | 93 | 55 | Upgrade
|
| Other Operating Activities | - | -843 | -693 | -400 | -360 | -668 | Upgrade
|
| Change in Accounts Receivable | - | -3,413 | -2,223 | -2,389 | 1,306 | -538 | Upgrade
|
| Change in Inventory | - | 424 | 191 | 564 | -2,402 | -289 | Upgrade
|
| Change in Accounts Payable | - | -281 | 1,020 | 74 | -1,095 | 417 | Upgrade
|
| Change in Other Net Operating Assets | - | 176 | 1,639 | -563 | 62 | -566 | Upgrade
|
| Operating Cash Flow | - | 12,116 | 8,491 | 465 | 2,988 | 4,173 | Upgrade
|
| Operating Cash Flow Growth | - | 42.69% | 1726.02% | -84.44% | -28.40% | -37.60% | Upgrade
|
| Capital Expenditures | - | -3,394 | -1,463 | -2,328 | -2,546 | -3,557 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 20 | 305 | 538 | 451 | 221 | Upgrade
|
| Cash Acquisitions | - | - | - | -1,031 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -193 | -593 | -99 | 23 | -29 | Upgrade
|
| Investment in Securities | - | -6,035 | -4,275 | 2,039 | -3,889 | 821 | Upgrade
|
| Other Investing Activities | - | -737 | 1,255 | 824 | 4,922 | 874 | Upgrade
|
| Investing Cash Flow | - | -10,327 | -4,771 | -53 | -1,033 | -1,670 | Upgrade
|
| Short-Term Debt Issued | - | 1,978 | - | 1,382 | - | - | Upgrade
|
| Total Debt Issued | - | 1,978 | - | 1,382 | - | - | Upgrade
|
| Short-Term Debt Repaid | - | - | -2,390 | - | -484 | -801 | Upgrade
|
| Long-Term Debt Repaid | - | -21 | -20 | -24 | -12 | -8 | Upgrade
|
| Total Debt Repaid | - | -21 | -2,410 | -24 | -496 | -809 | Upgrade
|
| Net Debt Issued (Repaid) | - | 1,957 | -2,410 | 1,358 | -496 | -809 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 1 | 475 | Upgrade
|
| Repurchase of Common Stock | - | -2,537 | -74 | - | - | -536 | Upgrade
|
| Common Dividends Paid | - | -1,708 | -1,004 | -822 | -1,139 | -1,274 | Upgrade
|
| Other Financing Activities | - | -181 | -142 | -188 | -223 | -364 | Upgrade
|
| Financing Cash Flow | - | -2,469 | -3,630 | 348 | -1,857 | -2,508 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 65 | 118 | 93 | -38 | -80 | Upgrade
|
| Net Cash Flow | - | -615 | 208 | 853 | 60 | -85 | Upgrade
|
| Free Cash Flow | - | 8,722 | 7,028 | -1,863 | 442 | 616 | Upgrade
|
| Free Cash Flow Growth | - | 24.10% | - | - | -28.25% | -70.97% | Upgrade
|
| Free Cash Flow Margin | - | 21.79% | 25.95% | -9.57% | 2.15% | 3.22% | Upgrade
|
| Free Cash Flow Per Share | - | 48.59 | 38.50 | -10.21 | 2.42 | 3.38 | Upgrade
|
| Cash Interest Paid | - | 181 | 142 | 170 | 128 | 221 | Upgrade
|
| Cash Income Tax Paid | - | 2,863 | 1,775 | 482 | 1,300 | 1,340 | Upgrade
|
| Levered Free Cash Flow | - | 4,558 | 1,964 | -1,849 | -385 | -710 | Upgrade
|
| Unlevered Free Cash Flow | - | 4,685 | 2,056 | -1,767 | -326.88 | -599.38 | Upgrade
|
| Change in Net Working Capital | - | 3,412 | 2,587 | 1,559 | 2,182 | 1,191 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.